UFP Technologies (UFPT) Investor presentation summary

Company overview and market position

• Specializes in contract development and manufacturing for medical devices, sterile packaging, and engineered products, with 92% of $603M annual revenue from MedTech.

• Serves 26 of the top 30 global medical OEMs, operating 21 manufacturing facilities and 6 innovation centers.

• Focuses on high-growth MedTech segments: single-use devices, robotic surgery, and sterile packaging.

Innovation and process

• Offers expertise in design, materials, and precision manufacturing with a global footprint.

• End-to-end process from design and prototyping to commercial production, integrating proprietary technologies and custom equipment.

• Deep experience in flexible material-based device manufacturing, fostering long-term customer relationships.

Market dynamics and growth strategy

• MedTech market valued at $550B with 6% CAGR; robotic surgery market projected to grow from $11B (2024) to $23.7B (2029).

• Internal growth leverages technology differentiation, engineering resources, and exclusive materials access.

• Strategic acquisitions target higher-growth, higher-margin MedTech opportunities, aiming for accretive results within a year.

• Proven track record with 22 acquisitions, transforming from diversified industrial to differentiated MedTech focus.